Arlington Capital Partners portfolio company AVS Bio has acquired ImmunoPrecise Antibodies Europe (IPA Europe). IPA Europe is a carve-out of ImmunoPrecise Antibodies, a biotherapeutics company ...

Arlington Capital Partners ("Arlington"), a Washington, D.C.-area private investment firm specializing in government regulated industries, today announced that its portfolio company AVS Bio, a leading ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("IPA" or the "Company"), a biotherapeutics company delivering advanced solutions ...

AI research is central to many of the deals. In April, French pharmaceutical giant Sanofi announced a $1.7 billion agreement ...

Key Points GAAP revenue of $864 million for Q2 2025 was flat year over year but exceeded analyst estimates by $9.92 million, or 1.16%. GAAP earnings per share were $0.49, matching analyst expectations ...

BP's announcement on Monday of its largest global oil and gas discovery in 25 years in Brazil's offshore Santos basin bodes ...

A new transnational coalition of Liberian citizens, diaspora leaders, activists, and scholars has officially launched the ...

Canaccord Genuity analyst Tim Hoff joins us for his third annual Diggers portfolio. Can he go back to back on his recent ...

Lobbyists and petrostates want to avoid a strong focus on human health in the impending global treaty on plastic pollution.

As Warner Bros. Discovery splits into two, HBO Max may be left without key content, such as sports. In early June, Warner Bros.

Biogen Inc. (NASDAQ:BIIB) is one of the top 10 medical AI companies to buy according to analysts. On July 14, UBS reiterated ...